Evaluation of Commercially Available Seizure Detection Wearables in Canada: Current Evidence.
Can J Neurol Sci
; : 1-4, 2024 Apr 04.
Article
em En
| MEDLINE
| ID: mdl-38572541
ABSTRACT
Wearable-based seizure detection devices hold promise in reducing seizure-related adverse events and relieving the daily stress experienced by people with epilepsy. In this work, we present the latest evidence regarding the performance of three seizure detection wearables (eight studies) commercially available in Canada to provide guidance to clinicians. Overall, their ability to detect focal-to-bilateral and/or generalized tonic-clonic seizures ranges between 21.0% and 98.15% in sensitivity, with the 24h false alarm rates ranging from 0 to 1.28. While performance in epilepsy monitoring units show promise, the lack of evidence in outpatient settings precludes strong recommendations for their use in daily life.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Can J Neurol Sci
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Canadá